Recommendations for the pharmacological management of neuropathic pain: an overview and literature update - Wikidata - awgldk - TriplyDB

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

http://www.wikidata.org/entity/Q24616897

about

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel Nortriptyline for neuropathic pain in adults Desipramine for neuropathic pain in adults Imipramine for neuropathic pain in adults Nortriptyline for neuropathic pain in adults Opioids for neuropathic pain Pregabalin for chronic prostatitis Lamotrigine for chronic neuropathic pain and fibromyalgia in adults Lacosamide for neuropathic pain and fibromyalgia in adults Lacosamide for neuropathic pain and fibromyalgia in adults Pregabalin for chronic prostatitis Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults Drug therapy for chronic idiopathic axonal polyneuropathy The search for novel analgesics: targets and mechanisms Diagnosis and treatment of pain in small-fiber neuropathy The endocannabinoid system, cannabinoids, and pain Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence Pain management strategies for neuropathic pain in Fabry disease--a systematic review Postoperative pain management Central changes associated with chronic pelvic pain and endometriosis Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.Cognitive Effects and Sedation.Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology Pathways in the diagnosis and management of diabetic polyneuropathy Neurotrophins and Neuropathic Pain: Role in Pathobiology Herpes zoster and postherpetic neuralgia in older adults The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica Exploring a clinically friendly web-based approach to clinical decision support linked to the electronic health record: design philosophy, prototype implementation, and framework for assessment MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.Orofacial pain management: current perspectives.

P2860

Q21261394-8420F73D-3902-4DB8-B8A4-276A7227EEC5 Q24186696-140A7CE3-FE2B-485C-AC73-98488151FF23 Q24193468-8A24DA9F-0292-40A1-A7E2-0AAFF003757E Q24194598-9607B88D-7CB8-45F6-A2DE-A565CFC453C2 Q24195022-20CAB80D-B7C9-4FB8-9E67-8241366035D1 Q24200179-E79FCA49-4FE5-4335-AB8F-D33F0775FE8F Q24201682-69F9BB41-AAEE-4926-A429-7E454E36685D Q24201979-EA583676-6E07-49DA-9424-122492464AA4 Q24203727-4AA66300-324E-419F-91D2-78DBD8604F47 Q24234774-BACCE5D2-4A42-4A49-BBBE-AB8FB550350C Q24235552-3F62753C-E9F4-412B-A37F-17616B1FA6BD Q24235890-1C51367E-9506-4FD6-BD57-986974468F76 Q24247228-77380824-8B67-4DE7-BC96-D1AA8D691EE0 Q24288817-3BF54775-C358-476B-A94B-3F50EF7BC813 Q24601427-ECFE5F04-4B03-4D29-B4AE-AB8940A2EC46 Q24601890-C9B4E3FA-08ED-4AC0-9080-784D8C4D4BF6 Q24623541-DA29136C-D4A7-451D-842F-787C21949637 Q24632762-7A284A22-0DF2-4BF5-A506-72591449C21E Q26741831-C614C3FA-BDBD-4275-8E8E-57F44A85DD8C Q26751458-B0E4EC6C-E0F6-4944-B2C9-0895FCC050AA Q26765263-8C8B4E48-6D55-4989-B334-EC1E3AB202D0 Q26766561-F9F7B8A1-E25B-44C6-BF26-3A8D5295A914 Q26828053-C0260C34-6104-4BCA-B66F-EB977109836D Q26851581-63898E10-D240-4CA2-92D3-79A14F40AC76 Q27004010-633BA8FB-2D48-407E-A4C5-8E2654321FFE Q27009981-BDA80EA4-BB1C-4415-B25A-F259C6E4CC7B Q27313058-826B04EA-46C7-45AF-9DB8-2A078FC34D58 Q27316372-13F8F687-C998-4FED-B8ED-7FAA61FF4C28 Q27686932-811B7205-E915-4E83-97AD-F2C623BC0FB6 Q28067298-1F95DF4B-7A0A-4158-8AAB-D3676A74E62B Q28068743-9D2BDF70-D230-4DBE-9A50-CF8D7D84E8E0 Q28069535-FE4E0373-0B1B-4A5C-BFC1-E191DB8F7C45 Q28077357-515638EC-EE8A-45A3-9035-5155902125FA Q28082465-05FDF3CD-94A8-4BF6-8EDA-3870BC61D68E Q28084413-2385A26C-8DE4-4AE7-AA8F-F5CB5C86634F Q28111717-F4FF75EB-4796-4C05-8812-45901E955856 Q28484151-D3C5B927-E348-4E90-A4D4-184A7E4FC8C7 Q30370691-6FDA82A3-D3CE-4B36-A3DE-3E4FAAE26FC1 Q30393753-18A712C2-DD2E-46F3-824E-416DD369F61F Q30442178-4E0E83F9-8784-4384-8620-DC4C42E510C6

P2860

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

http://www.wikidata.org/entity/Q24616897

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Recommendations for the pharma ...... overview and literature update

@ast

Recommendations for the pharma ...... overview and literature update

@en

Recommendations for the pharma ...... overview and literature update

@nl

type

label

Recommendations for the pharma ...... overview and literature update

@ast

Recommendations for the pharma ...... overview and literature update

@en

Recommendations for the pharma ...... overview and literature update

@nl

prefLabel

Recommendations for the pharma ...... overview and literature update

@ast

Recommendations for the pharma ...... overview and literature update

@en

Recommendations for the pharma ...... overview and literature update

@nl

P1433

Q24616897-DD581406-372B-4BA3-B63B-3C8CB9A483D1

P1476

Q24616897-58D87BE0-ECA3-4F96-AFC9-7F3A6CD5B748

P2093

Q24616897-1C284DB2-9B69-415A-BE91-E811728C0D35

Q24616897-2EB6AB7E-7F12-481A-815B-D800AD677E85

Q24616897-30CD9CF1-01DE-4088-AF42-A8E8443E1544

Q24616897-45F451F9-A89E-44CE-8682-372A2237F6E8

Q24616897-681B31F8-AFB9-4E24-8C8B-30CD545AB9BF

Q24616897-712017BB-EB85-41FE-A97C-0ACD1F2CD8BB

Q24616897-732858AA-8E38-449E-B45A-5F99F8347E28

Q24616897-75FE3EF7-0603-438A-888F-8A8E0BE05A81

Q24616897-87C6E83A-04CE-4BEA-ACB8-C08F900CB6BC

Q24616897-93A9BD64-5FB3-4D9D-8CB9-9F4CB0DFF728

P2860

Q24616897-00935741-6C54-4DAA-B993-60CE9728B3FB

Q24616897-0279AE0F-0BA9-4699-9ECF-2C3DE7C7FE4B

Q24616897-08861926-B3EE-4515-B821-C14B0CD3542F

Q24616897-118B138A-B0E7-4BAA-BA28-E664940FAD2F

Q24616897-14F1FA59-CF9E-41CF-80B1-01F84A1B7E5F

Q24616897-17825152-9E22-4F4E-A078-1002F04F9364

Q24616897-187CAFC2-2AC9-4D30-8BA9-574D1FE25620

Q24616897-1A177BE1-10BB-4DA8-9A72-05D972B77AAB

Q24616897-1D99E46A-FF55-445A-8E02-CDF94A0BFF5A

Q24616897-1FA2CC6C-C557-4BAF-BE0E-00F015633FA5

P304

Q24616897-6AB337A1-3538-4A12-B8D2-3B32AD364A24

P31

Q24616897-84D51361-4AFE-4082-B8DC-B4E2118F89C4

P3181

Q24616897-7220D36F-0140-4CBA-91A3-5AC76165AACE

P356

Q24616897-86CAFCB9-B5EE-4457-83D4-3B26DCBCF5A8

P407

Q24616897-45CDE5DF-970F-4C19-A249-56089D81099E

P433

Q24616897-15A8F157-FC26-49ED-8B09-605A66729E4E

P478

Q24616897-869CF4D8-6DCB-4B4F-9EAF-75BF1C27312C

P50

Q24616897-16B8D751-C22B-4173-A1D5-9A28BEB9BAB0

Q24616897-4D5ECE65-7FC4-4E40-B078-77B61B65505F

Q24616897-B142356D-CC84-4C96-8C40-3A28E9638E76

P577

Q24616897-D06BB700-A25E-44B9-BD80-C928444AD8A0

P5875

Q24616897-5EA93CC5-5015-4D74-92EB-CDB0BC2DAAFE

P698

Q24616897-F0D45E23-A460-45F3-B418-5A73C4791E91

P921

Q24616897-10DC21E9-0064-4472-BC73-3B464C12A35E

Q24616897-2ede74a8-c568-4939-8baa-66229b3f97f6

Q24616897-49060CE0-1DA6-483C-9678-75A862ED4F7C

P932

Q24616897-8C488BFF-E6C7-436D-B535-3984BD8A877D

P3181

P356

P1433

Mayo Clinic Proceedings

P1476

Recommendations for the pharma ...... overview and literature update

@en

P2093

Alyssa A Lebel

http://www.w3.org/2001/XMLSchema#string

Andrew S C Rice

http://www.w3.org/2001/XMLSchema#string

Brett Stacey

http://www.w3.org/2001/XMLSchema#string

Christopher D Wells

http://www.w3.org/2001/XMLSchema#string

Dennis C Turk

http://www.w3.org/2001/XMLSchema#string

Elliot J Krane

http://www.w3.org/2001/XMLSchema#string

Gary A Walco

http://www.w3.org/2001/XMLSchema#string

Geoffrey K Gourlay

http://www.w3.org/2001/XMLSchema#string

Joel L Kent

http://www.w3.org/2001/XMLSchema#string

John Mayer

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia.

Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin.

Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.

A novel tool for the assessment of pain: validation in low back pain

A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

P304

S3-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

761910

http://www.w3.org/2001/XMLSchema#string

P356

10.4065/MCP.2009.0649

http://www.w3.org/2001/XMLSchema#string

P407

P433

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Rolf-Detlef Treede

Alec B O'Connor

Christine Miaskowski

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51442347

http://www.w3.org/2001/XMLSchema#string

P698

20194146

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

pain management

P932

2844007

http://www.w3.org/2001/XMLSchema#string